124 related articles for article (PubMed ID: 7656086)
21. Examining product risk in context: the case of zomepirac.
Spielberg TE
JAMA; 1994 Oct; 272(16):1252; author reply 1252-3. PubMed ID: 7933364
[No Abstract] [Full Text] [Related]
22. Ketorolac.
Dubé JE
J Toxicol Clin Toxicol; 1994; 32(3):313. PubMed ID: 8007039
[No Abstract] [Full Text] [Related]
23. Ketorolac and gastrointestinal ulceration.
Fuller DK; Kalekas PJ
Ann Pharmacother; 1993; 27(7-8):978-9. PubMed ID: 8364288
[No Abstract] [Full Text] [Related]
24. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study.
Strom BL; Berlin JA; Kinman JL; Spitz PW; Hennessy S; Feldman H; Kimmel S; Carson JL
JAMA; 1996 Feb; 275(5):376-82. PubMed ID: 8569017
[TBL] [Abstract][Full Text] [Related]
25. Acute renal failure and ketorolac.
Buller GK; Perazella MA
Ann Intern Med; 1997 Sep; 127(6):493-4. PubMed ID: 9313014
[No Abstract] [Full Text] [Related]
26. Intramuscular ketorolac and morphine in the treatment of moderate to severe pain after major surgery.
Spindler JS; Mehlisch D; Brown CR
Pharmacotherapy; 1990; 10(6 ( Pt 2)):51S-58S. PubMed ID: 2082314
[TBL] [Abstract][Full Text] [Related]
27. Ketorolac (Toradol) for dental pain.
Wynn RL
Gen Dent; 1992; 40(6):476-9. PubMed ID: 1298670
[No Abstract] [Full Text] [Related]
28. Ketorolac: a new drug for relief of acute pain.
Corbett JV; Lagana K
MCN Am J Matern Child Nurs; 1994; 19(4):240. PubMed ID: 7934705
[No Abstract] [Full Text] [Related]
29. Ketorolac: a new antiinflammatory for seasonal allergic conjunctivitis.
Holdcroft C
Nurse Pract; 1994 May; 19(5):30. PubMed ID: 8065646
[No Abstract] [Full Text] [Related]
30. Ketorolac formulary restriction and usage evaluation.
Gianarkis DG
DICP; 1991 Dec; 25(12):1399. PubMed ID: 1844133
[No Abstract] [Full Text] [Related]
31. Comment: ketorolac formulary restriction and usage evaluation.
Baboolal SM; Mayo M
Ann Pharmacother; 1992 Sep; 26(9):1158-60. PubMed ID: 1421689
[No Abstract] [Full Text] [Related]
32. [Ketorolac-induced acute kidney failure].
Epelde Gonzalo FD; Llibre Bombardó J; Tomás Vecina S
Rev Clin Esp; 1994 Jun; 194(6):515. PubMed ID: 8079033
[No Abstract] [Full Text] [Related]
33. No harm was done.
Dies DF; Clarkston WK; Schratz CL
Am J Gastroenterol; 1997 Mar; 92(3):541-2. PubMed ID: 9068499
[No Abstract] [Full Text] [Related]
34. Bleeding diathesis after perioperative ketorolac.
O'Hara DA
Anesth Analg; 1992 Jan; 74(1):167-8; author reply 168-9. PubMed ID: 1734788
[No Abstract] [Full Text] [Related]
35. Reversible renal insufficiency following ketorolac therapy.
Fong J; Gora ML
Ann Pharmacother; 1993 Apr; 27(4):510-2. PubMed ID: 8477132
[No Abstract] [Full Text] [Related]
36. Intramuscular ketorolac.
Phillips G
Anaesth Intensive Care; 1994 Feb; 22(1):113. PubMed ID: 8160937
[No Abstract] [Full Text] [Related]
37. Use of ketorolac in sickle-cell disease and vaso-occlusive crisis.
Goodman E
Lancet; 1991 Sep; 338(8767):641-2. PubMed ID: 1679183
[No Abstract] [Full Text] [Related]
38. The effect of pretreatment with ketorolac on pain during intravenous injection of propofol.
Dexter TJ
Anaesthesia; 1997 Jan; 52(1):94. PubMed ID: 9014572
[No Abstract] [Full Text] [Related]
39. Ketorolac-induced acute renal failure and hyperkalemia.
Kelley M; Bastani B
Clin Nephrol; 1995 Oct; 44(4):276-7. PubMed ID: 8575131
[No Abstract] [Full Text] [Related]
40. [Reduce the dosage of ketorolac! Following EEC recommendations reduces the risk of hemorrhage with a marginal reduction of the analgesic effect].
Lagerkranser M; Belfrage M; Flordal PA; Persson E
Lakartidningen; 1996 Dec; 93(49):4543-4. PubMed ID: 8999239
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
